15F West Center 1 Building
26, Eulji-ro 5-gil, Jung-gu
Seoul, 04539 South Korea
Phone: + 82 2 6030 3300
Fax: + 82 2 6030 3399
Phone:
0079 814 800 9172
(Toll-free number)
For any questions regarding our products in Korea, please email: koreamedinfo@gilead.com.
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Gilead Sciences, Inc. does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site, and the opinions, claims, or comments expressed on this site should not be attributed to Gilead Sciences, Inc. Gilead Sciences, Inc. is not responsible for the privacy policy of any third‑party websites.
By clicking this link, you will be leaving the Gilead Medical Information website and will be redirected to the Gilead Corporate website.
Once redirected, click on "Global Operations" in the top right corner of the homepage and choose the country you are seeking Gilead product information in.
Gilead Sciences Korea Ltd. (the “Company”) may process (collect, use, provide, etc.) your personal information as follows in the course of receiving and responding to the medical information inquiries about the Company’s products to be submitted by you and fulfilling the Company’s obligations under applicable laws and regulations. We intend to obtain your consent to the processing of your personal information in accordance with applicable laws and regulations.
If you consent to the processing of your personal information by the Company,
please check the relevant boxes below.
| Collected Items |
|
| Purpose of Collection and Use |
|
| Period of Retention and Use | Unless the Company is otherwise obliged to preserve your personal information by applicable laws and regulations, the Company retains and uses your personal information for 7 years from the completion of processing of medical information inquiries. If an inquiry includes any adverse event after taking the Company’s product, the Company retains and uses your information for 25 years from the expiration or withdrawal date of the relevant product’s last license or approval on a global basis. If an inquiry includes complaints about the Company’s product, the Company retains and uses your information for 3 years from the expiration date/period of use of the relevant product’s batch. |
You have the right to refuse the collection and use of your personal information as set forth above. However, if you refuse, receiving, handling and responding to your inquiries may be restricted.
| Collected Items |
|
| Purpose of Collection and Use |
|
| Period of Retention and Use | Unless the Company is otherwise obliged to preserve your personal information by applicable laws and regulations, the Company may retain and use your sensitive information for 25 years from the expiration or withdrawal date of the relevant product’s last license or approval on a global basis. |
You have the right to refuse the collection and use of your personal information as set forth above. However, if you refuse, receiving, handling and responding to your inquiries may be restricted.
1You can find the current status of Gilead affiliates at http://
| Recipient Name (Contact Information) | Country Where Recipient is Located | Recipient’s Purpose of Using the Personal Information | Items of Personal Information to be Transferred | Period of Retention and Use by Recipient |
|---|---|---|---|---|
| Recipient Name (Contact Information) | ||||
|
Gilead Group Companies |
Country Where Recipient is Located
Gilead Sciences Inc.: U.S. Affiliates: About 40 countries excluding Ireland and Hong Kong |
Recipient’s Purpose of Using the Personal Information
Processing of medical information inquiries and provision of responses thereto (If an inquiry includes any adverse event after taking the Company’s product) Reporting of adverse events pursuant to the applicable laws and regulations, communication/business interactions amongst Gilead Group Companies, compliance with legal obligations of relevant jurisdictions, examination/audit etc. of compliance status, and for any and all purposes described in the purpose of collection and use in Section 1 above (If an inquiry includes any complaint about the Company’s product) Quality control of products and handling of complaints, product improvement, research and development, response to related disputes and evidence, compliance with applicable laws and internal regulations |
Items of Personal Information to be Transferred
General personal information and sensitive information you consent to collection and use in Section 1 above |
Period of Retention and Use by Recipient
For 7 years from the completion of processing of medical information inquiries (If an inquiry includes any adverse event after taking the Company’s product) For 25 years from the expiration or withdrawal date of the relevant product’s last license or approval on a global basis (If an inquiry includes any complaint about the Company’s product) For 3 years from the expiration date/period of use of the relevant product’s batch |
|
Drug Safety Country (https:// |
Country Where Recipient is Located
Korea |
Recipient’s Purpose of Using the Personal Information
Reporting of any adverse event pursuant to the applicable laws and regulations |
Items of Personal Information to be Transferred
General personal information and sensitive information you consent to collection and use by in Section 1 above |
Period of Retention and Use by Recipient
Until the timeline prescribed in the regulations of the Ministry of Food and Drug Safety |
You have the right to refuse the third-party transfer of your personal information as set forth above. However, if you refuse, receiving, handling and responding to your inquiries may be restricted.
| Recipient Name (Contact Information) | Country Where Recipient is Located | Recipient’s Purpose of Using the Personal Information | Items of Personal Information to be Transferred | Time/ |
Period of Retention and Use by Recipient |
|---|---|---|---|---|---|
| Recipient Name (Contact Information) | |||||
|
Gilead Group Companies |
Country Where Recipient is Located
Gilead Sciences Inc.: U.S. Affiliates: About 40 countries excluding Ireland and Hong Kong |
Recipient’s Purpose of Using the Personal Information
Processing of medical information inquiries and provision of responses thereto (If an inquiry includes any adverse event after taking the Company’s product) Reporting of adverse events pursuant to the applicable laws and regulations, communication/business interactions amongst Gilead Group Companies, compliance with legal obligations of relevant jurisdictions, examination/audit etc. of compliance status, and for any and all purposes described in the purpose of collection and use in Section 1 above (If an inquiry includes any complaint about the Company’s product) Quality control of products and handling of complaints, product improvement, research and development, response to related disputes and evidence, compliance with applicable laws and internal regulations |
Items of Personal Information to be Transferred
General personal information and sensitive information you consent to collection and use in Section 1 above |
Time/Method of Transfer
Transferred through telecommuni-cation network from time to time as needed |
Period of Retention and Use by Recipient
For 7 years from the completion of processing of medical information inquiries (If an inquiry includes any adverse event after taking the Company’s product) For 25 years from the expiration or withdrawal date of the relevant product’s last license or approval on a global basis (If an inquiry includes any complaint about the Company’s product) For 3 years from the expiration date/period of use of the relevant product’s batch |
You have the right to refuse the overseas transfer of your personal information as set forth above. However, if you refuse, receiving, handling and responding to your inquiries may be restricted.
To submit a medical inquiry form, you must provide consent for Gilead to collect, use, and transfer personal information.
Please go back and agree to terms, or exit to return to Gilead Korea Medical Information homepage